Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
Chiara LonatiLuca AfferiAndrea MariAndrea MinerviniWojciech KrajewskiMarco BorghesiGerald B SchulzMichael RinkFrancesco MontorsiAlberto BrigantiRenzo ColomboAlberto MartiniAndrea NecchiRoberto ContieriRodolfo HurlePaolo UmariStefania ZamboniClaudio SimeoneFrancesco SoriaGiancarlo MarraPaolo GonteroJeremy Yuen-Chun TeohTobias KlatteAnne-Sophie BajeotMathieu RoumiguiéMorgan RouprêtAlexandra Masson-LecomteEkaterina LaukhtinaAnne Sophie ValiquetteM Carmen MirAlessandro AntonelliSarah M H EinerhandKees HendricksenRoberto CarandoChristian D FankhauserPhilipp BaumeisterAgostino MatteiShahrokh F ShariatMarco Moschininull nullPublished in: World journal of urology (2022)
BCG could represent an effective treatment for T1 squamous BCa patients with neither pure SqCC nor LVI, while immediate RC should be preferred among T1 squamous BCa patients with pure SqCC or LVI at initial TURB specimen.